Merck buys specialist laboratory company
This article was originally published in Clinica
Executive Summary
Merck KGaA (Germany) is to acquire specialist laboratory company, Willi Fischer, pending regulatory approval. Frankfurt-based Fischer, which produces laboratory consumer goods and equipment, had 1995 turnover of around DM 40 million ($28 million). The company has more than 50 employees, who are expected to be retained in the merger with Merck subsidiary Bender & Hobein.
You may also be interested in...
New EU Filings
Obecabtagene autoleucel, Autolus Therapeutics’s investigational treatment for relapsed or refractory B cell precursor acute lymphoblastic leukemia, is among the latest products that have been filed for review by the European Medicines Agency for potential EU marketing approval.
P&G Restores Volume Growth In Beauty, Grooming After Pricing Run
Procter & Gamble reports strong consumer spending in the US and Europe after a 3% increase in product pricing over the past year. Dragging on fiscal third-quarter results, sales of SK-II in China fell 30% for the January-March period, while lower incidence of cough and cold impacted Health Care performance.
BMS Has A Strong Pipeline, But Access Challenges Remain
Bristol Myers Squibb’s head of major markets, Monica Shaw, wants to improve patients’ access to lifesaving therapies. And the group has several new products ready to roll.